BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2020 2:50:53 PM | Browse: 1328 | Download: 2329
Publication Name World Journal of Gastroenterology
Manuscript ID 55458
Country United States
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease
Manuscript Source Invited Manuscript
All Author List Matteo Tardelli
ORCID
Author(s) ORCID Number
Matteo Tardelli http://orcid.org/0000-0003-2232-7779
Funding Agency and Grant Number
Corresponding Author Matteo Tardelli, MSc, PhD, Lecturer, Postdoctoral Fellow, Division of Gastroenterology and Hepatology, Joan and Sanford I Weill Cornell Department of Medicine, Weill Cornell Medical College, 413 E. 69th Street, New York, NY 10013, United States. mat4005@med.cornell.edu
Key Words Lipid metabolism; Monoacylglycerol lipase; Non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Cannabinoid; Nuclear receptors
Core Tip Monoacylglycerol lipase inhibition/modulation is yet unappreciated however attractive therapeutic concept to limit liver disease as fatty acids may drive hepatocyte injury, fibrogenesis and change immune cells phenotype.
Publish Date 2020-07-07 14:50
Citation Tardelli M. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. World J Gastroenterol 2020; 26(25): 3577-3585
URL https://www.wjgnet.com/1007-9327/full/v26/i25/3577.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i25.3577
Full Article (PDF) WJG-26-3577.pdf
Full Article (Word) WJG-26-3577.docx